Login Register Continue as a Guest Related products - 4.84 out of 5 - - - - 5.00 out of 5 - 4.34 out of 5 -
Their reasons: No human data at all for KPV, TB-500, or MOTS-c Only small, poorly controlled studies for BPC-157 Poor characterization and inconsistent naming across the category Possible immune reactions Adverse event reports filed on BPC-157 MOTS-c and TB-500 are banned by WADA So the agencys scientists said no to everything
Styling LENIE AYCARDO
Galicia-Moreno M, Lucano-Landeros S, Monroy-Ramirez HC, Silva-Gomez J, Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J (2020) Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects
So, it was a little discouraging